These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20179808)

  • 1. Management of hot flashes in women with breast cancer.
    Kligman L; Younus J
    Curr Oncol; 2010 Feb; 17(1):81-6. PubMed ID: 20179808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hot flushes and breast cancer with positive hormone receptors: Mechanisms and management].
    Cavadias I; Rouzier R; Lerebours F; Héquet D
    Bull Cancer; 2020 Nov; 107(11):1171-1185. PubMed ID: 32988609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.
    Pandya KJ; Raubertas RF; Flynn PJ; Hynes HE; Rosenbluth RJ; Kirshner JJ; Pierce HI; Dragalin V; Morrow GR
    Ann Intern Med; 2000 May; 132(10):788-93. PubMed ID: 10819701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with Aromatase Inhibitors in Postmenopausal Women with Breast Cancer and the Possibility of Influencing Side Effects].
    Krásenská M
    Klin Onkol; 2016; 29 Suppl 3():S39-49. PubMed ID: 28118723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analyses.
    Hutton B; Yazdi F; Bordeleau L; Morgan S; Cameron C; Kanji S; Fergusson D; Tricco A; Straus S; Skidmore B; Hersi M; Pratt M; Mazzarello S; Brouwers M; Moher D; Clemons M
    Syst Rev; 2015 Aug; 4():114. PubMed ID: 26307105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective.
    Garreau JR; Delamelena T; Walts D; Karamlou K; Johnson N
    Am J Surg; 2006 Oct; 192(4):496-8. PubMed ID: 16978958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen-induced hot flashes.
    Loprinzi CL; Zahasky KM; Sloan JA; Novotny PJ; Quella SK
    Clin Breast Cancer; 2000 Apr; 1(1):52-6. PubMed ID: 11899390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
    Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
    Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen, hot flashes and recurrence in breast cancer.
    Mortimer JE; Flatt SW; Parker BA; Gold EB; Wasserman L; Natarajan L; Pierce JP;
    Breast Cancer Res Treat; 2008 Apr; 108(3):421-6. PubMed ID: 17541741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial.
    Van Patten CL; Olivotto IA; Chambers GK; Gelmon KA; Hislop TG; Templeton E; Wattie A; Prior JC
    J Clin Oncol; 2002 Mar; 20(6):1449-55. PubMed ID: 11896091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy.
    Derzko C; Elliott S; Lam W
    Curr Oncol; 2007 Dec; 14 Suppl 1(Suppl 1):S20-40. PubMed ID: 18087605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
    Cella D; Fallowfield LJ
    Breast Cancer Res Treat; 2008 Jan; 107(2):167-80. PubMed ID: 17876703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
    Johansson H; Gray KP; Pagani O; Regan MM; Viale G; Aristarco V; Macis D; Puccio A; Roux S; Maibach R; Colleoni M; Rabaglio M; Price KN; Coates AS; Gelber RD; Goldhirsch A; Kammler R; Bonanni B; Walley BA;
    Breast Cancer Res; 2016 Nov; 18(1):110. PubMed ID: 27825388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial.
    Dezentjé VO; Gelderblom H; Van Schaik RH; Vletter-Bogaartz JM; Van der Straaten T; Wessels JA; Kranenbarg EM; Berns EM; Seynaeve C; Putter H; Van de Velde CJ; Nortier JW; Guchelaar HJ
    Breast Cancer Res Treat; 2014 Jan; 143(1):171-9. PubMed ID: 24265036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors.
    Su HI; Sammel MD; Springer E; Freeman EW; DeMichele A; Mao JJ
    Breast Cancer Res Treat; 2010 Nov; 124(1):205-11. PubMed ID: 20182796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.
    Bordeleau L; Pritchard K; Goodwin P; Loprinzi C
    Clin Ther; 2007 Feb; 29(2):230-41. PubMed ID: 17472816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women.
    Moyad MA
    Urology; 2002 Apr; 59(4 Suppl 1):20-33. PubMed ID: 11937433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hot flashes and their management in breast cancer.
    Carpenter JS
    Semin Oncol Nurs; 2000 Aug; 16(3):214-25. PubMed ID: 10967794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer.
    Dent SF; Gaspo R; Kissner M; Pritchard KI
    Breast Cancer Res Treat; 2011 Apr; 126(2):295-310. PubMed ID: 21249443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The breast cancer continuum in hormone-receptor-positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors.
    Rugo HS
    Ann Oncol; 2008 Jan; 19(1):16-27. PubMed ID: 17693420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.